Testing effectiveness (Phase 2)Study completedNCT00848211What this trial is testingClinical Study of TUTI-16 in Asymptomatic HIV-1 Infected SubjectsWho this might be right forHIV Infections Thymon, LLC 24
Testing effectiveness (Phase 2)Study completedNCT00001045What this trial is testingComparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the DiseaseWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 300
Large-scale testing (Phase 3)Study completedNCT00000750What this trial is testingA Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV InfectionWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 400
Post-approval studies (Phase 4)Study completedNCT00002179What this trial is testingThe Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of InfectionWho this might be right forHIV Infections Merck Sharp & Dohme LLC 200
Not applicableWithdrawnNCT05571761What this trial is testingTeleneuropsychological Intervention in Asymptomatic HIV Seropositive Patients: N&C NeuroChangeWho this might be right forTelerehabilitationNeuropsychologyHIV Dementia Universidad Nacional Autonoma de Mexico
Testing effectiveness (Phase 2)UnknownNCT01067417What this trial is testingEvaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected PatientsWho this might be right forHIV Infections Medical Research Council 83
Not applicableEnded earlyNCT00001064What this trial is testingA Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00002106What this trial is testingA Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3Who this might be right forHIV Infections Glaxo Wellcome 104
Testing effectiveness (Phase 2)Study completedNCT00002079What this trial is testingPhase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)Who this might be right forHIV Infections G D Searle
Not applicableStudy completedNCT00002048What this trial is testingThe Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)Who this might be right forLymphatic DiseaseHIV Infections Glaxo Wellcome
Large-scale testing (Phase 3)Study completedNCT00002109What this trial is testingDouble-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral TherapyWho this might be right forHIV Infections Immunobiology Research Institute
Not applicableStudy completedNCT00002323What this trial is testingA Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ CellWho this might be right forHIV Infections Boehringer Ingelheim 60
Early research (Phase 1)Study completedNCT00000977What this trial is testingActive Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and ToxicityWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 52
Testing effectiveness (Phase 2)Study completedNCT01335191What this trial is testingClinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001)Who this might be right forHIV Infections Thymon, LLC 27
Early research (Phase 1)Study completedNCT00000664What this trial is testingSafety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic IndividualsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 26
Not applicableUnknownNCT00426374What this trial is testingAssessment of Asymptomatic Heart Disease in Children With HIVWho this might be right forHIV Infections Hadassah Medical Organization
Testing effectiveness (Phase 2)Study completedNCT00002324What this trial is testingThe Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the DiseaseWho this might be right forHIV Infections Boehringer Ingelheim 250
Not applicableStudy completedNCT00841360What this trial is testingID and Testing Via Friendship NetworksWho this might be right forAsymptomatic HIVHIV Infections University of North Carolina, Chapel Hill 535
Not applicableStudy completedNCT00002176What this trial is testingA Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV InfectionWho this might be right forHIV Infections Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT00002350What this trial is testingA Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected PatientsWho this might be right forHIV Infections Apollon 16